BDR Pharmaceuticals
  • Home
    • About BDR
    • CMD Profile
    • News
    • Blogs
    • Our Strengths
    • Facilities
    • Press Release
    • Company Policies
    • CSR Sustainability
    • Mission & Vision
    • Ethical Marketing Division
    • Milestones
    • Global Presence
    • Board of Directors
    About Us
  • Products
    • Innovation & Technology
    • Regulatory
    • Research & Development
    • IPR
    • Quality Policy
    • Contract Manufacturing
    Expertise
    • Culture
    • Job Openings
    Careers
  • Investors
  • Contact
  1. Home
  2. Press Release

Press Release

Innovative Breakthroughs in Pharmaceuticals: Press Releases and Updates

news ET Healthworld
Exclusive Story Jul 01, 2024

BDR Pharma to commercialise furmecil anti-cancer-drug for advanced gastric cancer

Read More
news MoneyControl
Exclusive Story Jul 01, 2024

CCI nods deal to acquire minority stake in BDR Pharma by Multiples Fund III and others

Read More
news Times Of India
Exclusive Story Jul 01, 2024

CCI nods deal to acquire minority stake in BDR Pharma by Multiples Fund III and others

Read More
news Business Today
Exclusive Story Jul 01, 2024

CCI nods deal to acquire minority stake in BDR Pharma by Multiples Fund III and others

Read More
news Business Standard
Exclusive Story Jul 01, 2024

CCI nods deal to acquire minority stake in BDR Pharma by Multiples Fund III and others

Read More
news Mint
Exclusive Story Jul 01, 2024

CCI nods deal to acquire minority stake in BDR Pharma by Multiples Fund III and others

Read More
  • ‹
  • 1
  • 2
  • 3
  • 4
  • ›

Print Media Coverage

Express Pharma

By 2023, pharma industry is expected to be worth more than $1 trillion

Firstpost

Prostate cancer: Symptoms, vulnerability and test options

mint

What Pharmaceutical India has accomplished in 2022: What to expect in 2023?

Financial Express

Living in a carcinogenic world (Editions) - Mumbai, New Delhi, Hyderabad, Kolkata, Chennai, Ahmedabad, Bangalore

TOI BLOGS

Prostate cancer: Unawareness, accessibility, and affordability sink the ship of men with prostate cancer

BW Healthcare

Why Pharma Companies Are Embracing Single-use Technology

Firstpost

Lung and Breast cancer: Bridging gap for newer therapies to deliver better clinical outcomes

MoneyControl

Will proposed drug database resolve lax monitoring of quality

TOI BLOGS

Uplifting barriers to becoming the pharmacy of the world

ET Healthworld

Role of high-end technology in R&D within pharma to reduce the cost of clinical trail

Express Pharma

Re-setting the pharma procurement value chain

Business Standard

Centre looking to phase out codeine-based cough syrups, select FDCs

FE Healthcare

Tablets and Capsules are the easiest forms of medication; How are they gaining prominence in cancer treatment?

DH Deccan Herald

Double whammy for economy: inflation rises, IIP growth slows

Times Of India

How will QR code on drug packaging help prevent the sale of spurious drugs

  • ‹
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • ›
Discover Previous
News Section
awards-cta
Discover Next
Ethical Marketing
certification-cta
footer-logo

BDR is a “niche” player in both global and domestic arena

Company
About BDR Milestones Our Mission & Vision Our Achivements CMD Profile
Expertise
Innovation & Technology Regulatory Research & Development IPR Quality Policy Contract Manufacturing
Quick Links
Home Products News Careers Contact
Registered Office

BDR Pharmaceuticals Internationals Pvt. Ltd. Registered Office, 407/408, Sharda Chambers, New Marine Lines, Mumbai 400020, India.

+91-22-40560560
Corporate Office

Grievance officer: Mr. Pawan Srivastava

Ombudsman, 6, Engineering Centre, 9 Mathew Road, Opera House, Mumbai- 400004, India.

+91-22-40560560
ombudsman@bdrpharma.com

Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at the buyer's risk. Products currently covered by valid patents in India are offered for R&D purpose in accordance with Section 107(A) of the Patents Act, 1970.

© BDR Pharmaceuticals International Pvt. Ltd, All Rights Reserved. Designed By Ideamagix.

Terms & Conditions | Privacy Policy

  • Home
  • About Us
    • Overview
    • Our Strengths
    • Achievements
    • CSR Sustainability
    • Milestones
    • CMD Profile
    • Facilities
    • Mission & Vision
    • Global Presence
    • News
    • Press Release
    • Ethical Marketing Division
    • Board Of Directors
    • Blogs
    • Company Policies
  • Products
  • Expertise
    • Innovation & Technology
    • Regulatory
    • Research & Development
    • IPR
    • Quality Policy
    • Contract Manufacturing
  • Careers
    • Culture
    • Job Openings
  • Investors
  • Contact